Randomized Trial of Fludarabine Versus Fludarabine and Idarubicin as Frontline Treatment in Patients With Indolent or Mantle-Cell Lymphoma

ZINZANI, P. L ; MAGAGNOLI, M ; LAUTA, V. M ; BENDANDI, M ; GHERLINZONI, F ; GENTILINI, P ; CICCONE, F ; CELLINI, C ; STEFONI, V ; RICCIUTI, F ; GOBBI, M ; TURA, S ; MORETTI, L ; DE RENZO, A ; BATTISTA, R ; ZACCARIA, A ; GUARDIGNI, L ; MAZZA, P ; MARRA, R ; RONCONI, F

Journal of clinical oncology, 2000-02, Vol.18 (4), p.773-779 [Periódico revisado por pares]

Baltimore, MD: American Society of Clinical Oncology

Sem texto completo